Picture this: you’re enjoying an unexpectedly warm February afternoon, taking advantage of the sunshine to explore your favorite hiking trail. The snow has melted, birds are chirping, and it feels like nature is awakening early. But lurking in that seemingly innocent winter landscape is a danger that defies our most basic assumptions about seasonal safety. While you’re savoring the premature taste of spring, tiny arachnids that should be dormant are actively seeking their next blood meal—and the diseases they carry don’t take winter vacations.
The comfortable predictability of “tick season” is rapidly becoming a relic of the past. What once confined our vigilance to the warmer months of spring through fall has evolved into a year-round health concern that’s catching both outdoor enthusiasts and healthcare professionals off guard. From the forests of Sweden to the hills of Bavaria, from California’s diverse ecosystems to Pennsylvania’s winters, the evidence is mounting: climate change has fundamentally altered the rules of tick behavior. As these disease vectors extend their active periods and expand their territories, we’re confronting a new reality where the luxury of seasonal complacency no longer exists.
The New Reality: Year-Round Tick Activity
The old rules about tick season are crumbling. While we’ve long thought of ticks as spring-through-fall creatures that hibernate through winter, climate change is rewriting this fundamental assumption. In Sweden, researchers made a startling discovery when they examined wild roe deer across three winter seasons: they found Ixodes ricinus ticks active on 243 individual occasions during the coldest months between December and February. These weren’t just stragglers from autumn — analysis of 65 ticks using specialized techniques showed many had actually attached to their hosts during winter itself.
The implications extend far beyond Scandinavia. In Bavaria, health officials note that ticks now exhibit heightened winter activity due to fewer frost days, creating what they describe as “nearly year-round risk of transmission” for diseases like TBE and Lyme disease. California health authorities echo this reality, stating that while risk varies by species and season, exposure to tick-borne diseases is generally year-round. Even Pennsylvania, despite its harsh winters, warns that tick encounters remain possible on warm winter days.
This shift represents more than just extended seasons — it’s a fundamental change in tick ecology that’s catching both the public and healthcare systems off guard. Traditionally, Ixodes ricinus follows a bimodal pattern with peaks in spring-early summer and late summer, allowing for predictable prevention strategies. But when researchers in Sweden tracked the same deer up to 10 times per winter at weekly intervals, they documented consistent tick activity throughout months that should have been tick-free. The Swedish study’s meticulous approach — examining 140 individual roe deer across 332 occasions at two climatically different sites — provides solid evidence that this isn’t an isolated phenomenon.
What makes this particularly concerning is the disease transmission potential. Unlike the old seasonal model where we could largely forget about tick-borne diseases from November through March, year-round activity means year-round vigilance. The warming trends that reduce frost days don’t just extend existing seasons — they’re creating entirely new windows of risk when our guard is typically down. For hikers enjoying an unseasonably warm February day or children playing in winter sunshine, the assumption that “it’s too cold for ticks” is becoming dangerously outdated.
But what’s driving this dramatic shift in tick behavior? The answer lies in the broader environmental changes reshaping our planet.
Climate Change Drives Disease Expansion
The evidence is mounting: climate change isn’t just melting glaciers and intensifying storms—it’s fundamentally reshaping the landscape of infectious disease. When we look at Ixodes ricinus, the primary tick species spreading Lyme disease and tick-borne encephalitis across Europe, we see a creature perfectly positioned to exploit our warming world. Research published in the International Journal of Environmental Research and Public Health shows that climate change is exacerbating the spread of Ixodes ricinus and increasing the occurrence of both Lyme borreliosis and tick-borne encephalitis throughout Europe. What makes this particularly concerning is how these tiny arachnids respond to the specific climate variables that are shifting most dramatically.
Temperature patterns tell a revealing story about tick expansion. The most comprehensive modeling study to date, which analyzed over 70,000 tick records, found that the amount of sunlight in January emerged as the most influential environmental factor for tick distribution. This finding illuminates why climate change poses such a threat: warmer winters with more sunshine help ticks overwinter successfully, extending their active season and boosting survival rates. In Russia, a 35-year-long dataset demonstrated an increase in adult Ixodes ricinus abundance that could be related to a lengthening of the tick activity season. We’re witnessing a fundamental shift where ticks no longer retreat during traditionally inhospitable months, maintaining their threat year-round.
The geographical implications are staggering when we examine the European landscape. Current projections show that France has nearly 620,000 km² of land suitable for ticks, while Spain has 506,000 km² suitable for tick colonization. To put this in perspective, between 50% of land in the UK and 95% of land in Spain offers habitat classified as medium-high suitability for ticks. These aren’t projections for some distant future—they represent current conditions that will only intensify as greenhouse gas emissions continue to alter regional climates.
Perhaps most telling are the early warning signals already documented across the continent. Shifts in altitudinal limits of Ixodes ricinus were first observed in Eastern Europe and then in the Alps, serving as some of the first concrete evidence of climate change effects on tick distribution. These upward migrations into previously unsuitable high-altitude areas represent more than just range expansion—they signal the breakdown of natural barriers that once contained tick-borne disease risks to specific regions. Climate models are now being used as a risk assessment approach to predict and evaluate the spread of tick-borne diseases, but the models consistently show that we’re racing to keep up with changes that are already underway.
Interestingly, while most research focuses on expanding tick populations, some recent modeling suggests a more complex picture. Research published on December 1, 2025 indicates that models project decreasing tick abundance under severe climate change scenarios, suggesting that extreme heat may eventually limit some populations. However, this potential future constraint offers little comfort for the immediate decades ahead, when the sweet spot of warmer-but-not-extreme conditions will likely create optimal breeding grounds across vast new territories. The challenge for public health officials is preparing for a world where disease vectors operate by entirely new rules, expanding into regions with little historical experience managing tick-borne diseases.
This expanding threat is already manifesting in alarming disease statistics across affected regions.
Rising Disease Burden: TBE and Lyme Statistics
The numbers tell a sobering story: tick-borne diseases are surging across Europe and beyond, with surveillance data revealing an escalating public health challenge. The EU/EEA reports an average of over 3,000 cases of tick-borne encephalitis (TBE) each year, while Lyme borreliosis dwarfs even these concerning figures. According to comprehensive European surveillance data, an average of 132,000 Lyme borreliosis cases were reported annually to European surveillance systems between 2015 and 2023. These aren’t just abstract statistics—they represent hundreds of thousands of people whose lives have been disrupted by infections that can cause everything from chronic fatigue to permanent neurological damage.
The geographic distribution of these diseases reveals particularly troubling hotspots across the continent. Estonia, Finland, and Slovenia reported the highest incidence rates of Lyme borreliosis, exceeding 100 cases per 100,000 population per year, painting a stark picture of northern and eastern European vulnerability. Even more alarming is the scope of population at risk: a minimum of 223 million people, representing 30% of the entire European population, live in areas with high Lyme borreliosis incidence of 10 or more cases per 100,000 people annually. This means nearly one in three Europeans lives in a zone where tick encounters carry significant disease risk.
Recent trends suggest the situation is deteriorating rather than stabilizing. While there were temporary decreases in Lyme borreliosis incidence during 2019-2021, incidence increased from 2021 to 2023 across Europe. Most concerning is the acceleration we’re witnessing: incidence of Lyme borreliosis increased an average of 36% in the last two years of reporting (2022-2023) for nearly 70% of European countries with recently published surveillance data. This sharp uptick coincides with changing tick behavior patterns, as these disease vectors are no longer confined to their traditional seasonal windows.
The timing of these infections reflects the expanding threat window we now face. Traditionally, most cases of TBE occur between May and November, but emerging evidence suggests ticks are active beyond these conventional boundaries. In the United States, the CDC reported over 89,000 confirmed Lyme disease cases in 2023, though estimates based on insurance claims suggest the actual number of diagnosed and treated cases could be as high as 476,000 annually. This massive underreporting gap—where actual cases may be five times higher than confirmed ones—hints that European surveillance systems likely capture only a fraction of the true disease burden as well.
Fortunately, effective medical countermeasures exist for at least one of these diseases, offering hope in our fight against tick-borne threats.
TBE Vaccination: Current Options and Guidelines
When it comes to protecting ourselves against tick-borne encephalitis, we have a powerful tool at our disposal, though it’s relatively new to American medicine. TICOVAC, the only TBE vaccine available in the United States, received FDA approval in August 2021 according to Wikipedia — a remarkably recent addition to our vaccine arsenal considering the first TBE vaccine was actually developed way back in 1937. This means that for decades, European travelers had access to protection that Americans simply couldn’t get domestically.
The vaccination schedule requires some planning ahead, which is crucial given that ticks are no longer limiting their activity to traditional seasons. TICOVAC is approved for anyone aged 1 year and older, but the dosing varies by age group. Adults 16 and older receive their first two doses spaced anywhere from 14 days to 3 months apart, followed by a third dose 5-12 months later. Children between 1-15 years follow a slightly different timeline, with the first two doses spaced 1-3 months apart before that crucial third dose. The key takeaway? You can’t get vaccinated the week before your hiking trip to Austria — this is a commitment that spans nearly a year.
The good news is that this commitment pays off handsomely. More than 87% of people who receive the vaccine develop immunity, making it highly effective protection against a disease that can cause severe neurological complications. The World Health Organization takes TBE vaccination seriously enough to recommend immunizing all people in areas where the disease is common, while suggesting it for high-risk individuals elsewhere. For those who complete the initial three-dose series, booster doses may be given at least 3 years after completion if ongoing exposure to TBE virus is expected.
Recent findings presented at IDWeek 2025 have reinforced just how important this vaccination conversation has become. Research highlighted the persistent risk of tick-borne encephalitis among international travelers and emphasized the importance of vaccination for individuals visiting endemic areas in Europe. The reality is that you can’t simply order TICOVAC online — you’ll need to work with your primary care physician or visit a travel medicine clinic. This might seem inconvenient, but given that we’re dealing with a disease that can cause lasting neurological damage, having medical oversight of the vaccination process makes perfect sense.
While TBE vaccination provides solid protection against one tick-borne threat, developments are also emerging for the more common Lyme disease.
Lyme Disease Vaccine Breakthrough: VLA15 Progress
After decades without a Lyme disease vaccine, we’re finally seeing promising results from the most advanced candidate in development. Pfizer and Valneva announced on March 23, 2026, that their vaccine candidate PF-07307405 (formerly known as VLA15) demonstrated 73.2% efficacy in preventing Lyme disease starting 28 days after the fourth dose in their Phase 3 VALOR trial. The investigational vaccine showed even stronger performance when measured from just one day after the fourth dose, with 74.8% efficacy in reducing confirmed Lyme disease cases compared to placebo. This 6-valent OspA-based vaccine is designed for individuals aged five years and above, potentially filling a massive gap in our tick-borne disease defenses.
The vaccine’s design reflects sophisticated understanding of Lyme disease’s complexity across continents. News reports that VLA15 targets six clinically relevant OspA serotypes from Borrelia burgdorferi sensu lato strains prevalent in both North America and Europe. This broad coverage is crucial because different regions harbor different strains of the Lyme bacteria. Earlier Phase 2 trials showed that children and adolescents demonstrated higher antibody responses than adults, suggesting the vaccine might be particularly effective in younger populations who often spend more time outdoors. The three-dose schedule (administered at 0, 2, and 6 months) produced higher antibody levels than two-dose regimens, helping researchers optimize the vaccination protocol.
However, the trial faced an unexpected statistical hurdle that highlights the challenges of vaccine development. NBC News reported that while the vaccine showed strong efficacy, it missed its main statistical goal due to fewer-than-anticipated Lyme cases during the study period. The trial required that the vaccine maintain at least 20% effectiveness even in a worst-case scenario, but the first analysis showed only 15.8% efficacy at the lower confidence interval. This statistical miss caused Valneva’s U.S.-listed shares to tumble more than 35% in premarket trading, even though a second planned analysis did meet the statistical threshold with 74.8% efficacy.
Despite the statistical complexities, the safety profile remains encouraging, with no safety concerns identified at the time of analysis according to both Pfizer and Valneva. The companies are now planning regulatory submissions, which could finally provide the first approved Lyme disease vaccine since GSK discontinued Lymerix in 2002. With the CDC estimating that approximately 476,000 people are diagnosed and treated for Lyme disease annually in the United States, according to NBC News, the need for effective prevention has never been more urgent. The timing couldn’t be more critical, as ticks are increasingly active year-round, expanding the window of risk for outdoor enthusiasts and anyone spending time in tick-prone areas.
While vaccines offer promising future protection, immediate defense relies on proven prevention strategies that must now be adapted for year-round vigilance.
Prevention Strategies for Year-Round Protection
The reality of year-round tick vigilance has fundamentally changed how we approach outdoor safety. While Pa acknowledges that “the risk of tick encounters is low in the winter, it is still possible on warm winter days,” this shift means we can no longer rely on seasonal complacency. The traditional tick calendar has been rewritten by climate patterns that create unpredictable pockets of activity throughout the year. When temperatures spike during what should be dormant months, ticks emerge ready to feed, catching unprepared outdoor enthusiasts off guard.
The foundation of effective tick prevention remains a multi-layered approach that the EPA has refined over decades of research. Their comprehensive strategy starts with habitat awareness: reducing time in tick-infested areas like tall grass and shrubs, walking in trail centers to avoid vegetation contact, and maintaining property by removing leaf litter and mowing tall grass. The clothing strategy is equally crucial — long-sleeved shirts, long pants, and high boots create physical barriers, while tucking shirts into pants and pants into socks eliminates the gaps where ticks typically gain access. Light-colored clothing serves a dual purpose, making tick detection significantly easier during and after outdoor activities.
Chemical protection adds another critical defense layer, with OSHA recommending permethrin treatment for clothes and gear following EPA guidelines. This approach transforms your outdoor gear into a protective shield that repels ticks on contact. The NYC Health Department emphasizes using EPA-registered tick repellents as part of their multi-step prevention approach, particularly important given that most New Yorkers contract tick-borne diseases outside the city in areas like Long Island, upstate New York, and Connecticut. Their surveillance has identified disease-carrying blacklegged ticks primarily on Staten Island and in the North Bronx, with 2,832 preliminary Lyme disease cases reported among city residents in 2024.
Post-exposure protocols are where many people fail in their prevention strategy, yet they’re arguably the most important step. OSHA recommends thorough body checks for ticks after exposure, followed immediately by showering and washing or drying clothing at high temperatures. The NYC Health Department extends this guidance to include checking children and pets, recognizing that ticks don’t discriminate in their choice of hosts. With the 2026 tick forecast projecting a 15-20% increase in populations nationwide and an extended active season from May 15 to July 15 representing the critical Lyme transmission window, these post-exposure rituals become even more vital. The combination of earlier season starts, longer duration activity, and expanding geographic ranges means that a single oversight in tick checks could have serious health consequences.
Conclusion
The transformation of tick-borne disease risk from a seasonal concern to a year-round reality represents one of climate change’s most immediate and tangible impacts on human health. We’re witnessing the collapse of predictable patterns that have guided public health strategies for generations, replaced by a complex new landscape where vigilance can never truly rest. The convergence of expanding tick populations, rising disease incidence, and evolving prevention needs demands nothing less than a complete reimagining of how we approach outdoor safety and public health preparedness.
As we stand at this inflection point, with promising vaccines on the horizon but immediate threats requiring daily vigilance, the question becomes not whether we can adapt to this new reality, but how quickly we can transform our collective mindset from seasonal caution to constant awareness. In a world where a warm February day might harbor the same risks as a humid July afternoon, are we prepared to abandon the comfort of seasonal predictability in favor of the persistent vigilance that our changing climate now demands?
